Focused ultrasound for treatment of peripheral brain tumors

Malignant brain tumors are the leading cause of cancer-related death in children and remain a significant cause of morbidity and mortality throughout all demographics. Central nervous system (CNS) tumors are classically treated with surgical resection and radiotherapy in addition to adjuvant chemoth...

Full description

Saved in:
Bibliographic Details
Main Authors: Phillip Mitchell Johansen, Payton Yerke Hansen, Ali A. Mohamed, Sarah J. Girshfeld, Marc Feldmann, Brandon Lucke-Wold
Format: Article
Language:English
Published: Open Exploration 2023-04-01
Series:Exploration of Drug Science
Subjects:
Online Access:https://www.explorationpub.com/uploads/Article/A10089/10089.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825199287202480128
author Phillip Mitchell Johansen
Payton Yerke Hansen
Ali A. Mohamed
Sarah J. Girshfeld
Marc Feldmann
Brandon Lucke-Wold
author_facet Phillip Mitchell Johansen
Payton Yerke Hansen
Ali A. Mohamed
Sarah J. Girshfeld
Marc Feldmann
Brandon Lucke-Wold
author_sort Phillip Mitchell Johansen
collection DOAJ
description Malignant brain tumors are the leading cause of cancer-related death in children and remain a significant cause of morbidity and mortality throughout all demographics. Central nervous system (CNS) tumors are classically treated with surgical resection and radiotherapy in addition to adjuvant chemotherapy. However, the therapeutic efficacy of chemotherapeutic agents is limited due to the blood-brain barrier (BBB). Magnetic resonance guided focused ultrasound (MRgFUS) is a new and promising intervention for CNS tumors, which has shown success in preclinical trials. High-intensity focused ultrasound (HIFU) has the capacity to serve as a direct therapeutic agent in the form of thermoablation and mechanical destruction of the tumor. Low-intensity focused ultrasound (LIFU) has been shown to disrupt the BBB and enhance the uptake of therapeutic agents in the brain and CNS. The authors present a review of MRgFUS in the treatment of CNS tumors. This treatment method has shown promising results in preclinical trials including minimal adverse effects, increased infiltration of the therapeutic agents into the CNS, decreased tumor progression, and improved survival rates.
format Article
id doaj-art-b2b8aaee2fc44a92b8498999b9fee9c9
institution Kabale University
issn 2836-7677
language English
publishDate 2023-04-01
publisher Open Exploration
record_format Article
series Exploration of Drug Science
spelling doaj-art-b2b8aaee2fc44a92b8498999b9fee9c92025-02-08T05:16:47ZengOpen ExplorationExploration of Drug Science2836-76772023-04-011210712510.37349/eds.2023.00009Focused ultrasound for treatment of peripheral brain tumorsPhillip Mitchell Johansen0https://orcid.org/0000-0003-1638-2325Payton Yerke Hansen1https://orcid.org/0000-0003-0195-2524Ali A. Mohamed2https://orcid.org/0000-0002-0977-0365Sarah J. Girshfeld3https://orcid.org/0009-0006-9029-2933Marc Feldmann4Brandon Lucke-Wold5https://orcid.org/0000-0001-6577-4080Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL 33431, USACharles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL 33431, USACharles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL 33431, USACharles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL 33431, USACollege of Medicine, University of Florida, Gainesville, FL 32611, USADepartment of Neurosurgery, University of Florida, Gainesville, FL 32611, USAMalignant brain tumors are the leading cause of cancer-related death in children and remain a significant cause of morbidity and mortality throughout all demographics. Central nervous system (CNS) tumors are classically treated with surgical resection and radiotherapy in addition to adjuvant chemotherapy. However, the therapeutic efficacy of chemotherapeutic agents is limited due to the blood-brain barrier (BBB). Magnetic resonance guided focused ultrasound (MRgFUS) is a new and promising intervention for CNS tumors, which has shown success in preclinical trials. High-intensity focused ultrasound (HIFU) has the capacity to serve as a direct therapeutic agent in the form of thermoablation and mechanical destruction of the tumor. Low-intensity focused ultrasound (LIFU) has been shown to disrupt the BBB and enhance the uptake of therapeutic agents in the brain and CNS. The authors present a review of MRgFUS in the treatment of CNS tumors. This treatment method has shown promising results in preclinical trials including minimal adverse effects, increased infiltration of the therapeutic agents into the CNS, decreased tumor progression, and improved survival rates.https://www.explorationpub.com/uploads/Article/A10089/10089.pdflow-intensity focused ultrasoundhigh-intensity focused ultrasoundmagnetic resonance guided focused ultrasoundmagnetic resonance-guided therapyglioblastoma
spellingShingle Phillip Mitchell Johansen
Payton Yerke Hansen
Ali A. Mohamed
Sarah J. Girshfeld
Marc Feldmann
Brandon Lucke-Wold
Focused ultrasound for treatment of peripheral brain tumors
Exploration of Drug Science
low-intensity focused ultrasound
high-intensity focused ultrasound
magnetic resonance guided focused ultrasound
magnetic resonance-guided therapy
glioblastoma
title Focused ultrasound for treatment of peripheral brain tumors
title_full Focused ultrasound for treatment of peripheral brain tumors
title_fullStr Focused ultrasound for treatment of peripheral brain tumors
title_full_unstemmed Focused ultrasound for treatment of peripheral brain tumors
title_short Focused ultrasound for treatment of peripheral brain tumors
title_sort focused ultrasound for treatment of peripheral brain tumors
topic low-intensity focused ultrasound
high-intensity focused ultrasound
magnetic resonance guided focused ultrasound
magnetic resonance-guided therapy
glioblastoma
url https://www.explorationpub.com/uploads/Article/A10089/10089.pdf
work_keys_str_mv AT phillipmitchelljohansen focusedultrasoundfortreatmentofperipheralbraintumors
AT paytonyerkehansen focusedultrasoundfortreatmentofperipheralbraintumors
AT aliamohamed focusedultrasoundfortreatmentofperipheralbraintumors
AT sarahjgirshfeld focusedultrasoundfortreatmentofperipheralbraintumors
AT marcfeldmann focusedultrasoundfortreatmentofperipheralbraintumors
AT brandonluckewold focusedultrasoundfortreatmentofperipheralbraintumors